FDA issued a Warning Letter to Hospira Inc on 2/14/2017 for a previous inspection.
483 Hospira A Pfizer Company Oct 2017

483 Hospira A Pfizer Company Oct 2017

Robert Ham FDA, Eric Padgett FDA, Michele Perry-Williams FDA, Sarah Rhoades FDA$119.00 - Available Now

FDA investigators audited the Hospira A Pfizer Company - Mcpherson, KS, United States facility and issued inspectional observations (via FDA 483) on 27 Oct 2017.

Product details

  • Category: Human Drugs / Medical Devices & Rad Health / Animal Drugs & Feeds
  • Inspection end: 27 Oct 2017
  • Location: Mcpherson, United States
  • FEI: 1925262
Add To Cart